Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limitedverified

BXPHF

Price:

$0.0764

Market Cap:

$236.24M

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that ...[Read more]

Industry

Biotechnology

IPO Date

2019-09-09

Stock Exchange

OTC

Ticker

BXPHF

The Enterprise Value as of December 2025 (TTM) for Botanix Pharmaceuticals Limited (BXPHF) is 172.49M

According to Botanix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 172.49M. This represents a change of -64.56% compared to the average of 486.74M of the last 4 quarters.

Botanix Pharmaceuticals Limited (BXPHF) Historical Enterprise Value (quarterly & annually)

How has BXPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of Botanix Pharmaceuticals Limited over the last ten years is 136.37M. The current 172.49M Enterprise Value has changed 12.55% with respect to the historical average. Over the past ten years (40 quarters), BXPHF's Enterprise Value was at its highest in in the June 2010 quarter at 11.41B. The Enterprise Value was at its lowest in in the January 2006 quarter at 0.

Quarterly (TTM)
Annual

Average

136.37M

Median

52.42M

Minimum

1.08M

Maximum

526.65M

Botanix Pharmaceuticals Limited (BXPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Botanix Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.10%

Maximum Annual Enterprise Value = 526.65M

Minimum Annual Increase = -90.96%

Minimum Annual Enterprise Value = 1.08M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025526.65M33.78%
2024393.68M181.68%
2023139.76M189.33%
202248.31M-14.56%
202156.54M359.90%
202012.29M-90.96%
2019136.04M273.45%
201836.43M181.29%
201712.95M1.10%
20161.08M-14.88%

Botanix Pharmaceuticals Limited (BXPHF) Average Enterprise Value

How has BXPHF Enterprise Value performed in the past?

The current Enterprise Value of Botanix Pharmaceuticals Limited (BXPHF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

353.37M

5-year avg

232.99M

10-year avg

136.37M

Botanix Pharmaceuticals Limited (BXPHF) Enterprise Value vs. Peers

How is BXPHF’s Enterprise Value compared to its peers?

Botanix Pharmaceuticals Limited’s Enterprise Value is greater than Innate Pharma S.A. (127.45M), greater than NDT Pharmaceuticals Inc. (158.40M), greater than Molecular Partners AG (46.65M), greater than Scancell Holdings plc (104.92M), greater than Brii Biosciences Limited (-453311803.63), less than JW (Cayman) Therapeutics Co. Ltd (886.64M), less than Hofseth BioCare ASA (562.31M), less than Ascend Wellness Holdings, Inc. (312.02M), less than Kintor Pharmaceutical Limited (824.17M), less than NervGen Pharma Corp. (442.70M),

Build a custom stock screener for Botanix Pharmaceuticals Limited (BXPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Botanix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Botanix Pharmaceuticals Limited (BXPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Botanix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Botanix Pharmaceuticals Limited's Enterprise Value?

What is the highest Enterprise Value for Botanix Pharmaceuticals Limited (BXPHF)?

What is the 3-year average Enterprise Value for Botanix Pharmaceuticals Limited (BXPHF)?

What is the 5-year average Enterprise Value for Botanix Pharmaceuticals Limited (BXPHF)?

How does the current Enterprise Value for Botanix Pharmaceuticals Limited (BXPHF) compare to its historical average?